Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARHGAP23 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BACE1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CNTN2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC48A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ERBB3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GPR37 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
USP54 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FAM124A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TRPM6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SYNJ2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LIG3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CDR2L - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RHOU - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FAXDC2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TTYH2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ZEB2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
IWS1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARHGEF2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ALCAM - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TCF12 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on